Non-Functioning Pituitary Adenomas: A Single Center Experience

Abstract

Introduction: To describe the clinical imaging and hormonal characteristics and the natural course of patients with clinically non-functioning pituitary adenomas (NFPAs) presenting at our department from 1984 to 2009.

Materials and methods: Retrospective review of electronic medical records of patients with NFPAs. The patients underwent basal and dynamic evaluation of the hypothalamic-pituitary axis. Size and functional alterations were estimated at yearly intervals.

Results: 114 patients (55 men and 59 women, aged 47±2) were studied. The mean follow-up time was 55±6 months (range 0–240). 45% of the adenomas were incidentally discovered and 75% were macroadenomas (73% with extrasellar extension). At diagnosis, 53% had headache and 76% of those with macroadenomas had visual field defects. Disruption of ≥1 pituitary axes was identified in 31% of patients at diagnosis. Surgery was performed in 59% and radiotherapy in 9% of the cases. 88% of surgically treated patients reported improvement in headache and 59% in visual fields. However, the prevalence of permanent diabetes insipidus increased from 2% at diagnosis to 15% postoperatively. The prevalence of ≥1 pituitary deficiencies and panhypopituitarism increased significantly postoperatively. 58% of the adenomas relapsed in size. 29% of the patients were managed conservatively and tumor size remained stable in 83% of them.

Conclusions: The majority of NFPAs not selected for surgery at diagnosis remained stable in size. Pituitary dysfunction and visual defects at diagnosis were common. Surgical debulking led to clinical improvement, but relapse occurred in 2/3 of the cases.

Key words

non-functioning pituitary adenomas - pituitary incidentaloma - hypopituitarism - transsphenoidal surgery

References

• 1 Arita K, Tominaga A, Sugiyama K. et al . Natural course of incidentally found nonfunctioning pitauitary adenoma, with special reference to pituitary apoplexy during follow-up examination.  J Neurosurg. 2006;  104 884-891
• 2 Barker 2nd FG, Klibanski A, Swearingen B. Transsphenoidal Surgery for Pituitary Tumors in the United States, 1996–2000: Mortality, Morbidity, and the Effects of Hospital and Surgeon Volume.  J Clin Endocrinol Metab. 2003;  88 4709-4719
• 3 Bates PR, Carson MN, Trainer PJ. et al . UK National Acromegaly Register Study Group (UKAR-2) Wide variation in surgical outcomes for acromegaly in the UK.  Clin Endocrinol (Oxf). 2008;  68 136-142
• 4 Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: lassifications and correlations to clinical data.  Eur J Endocrinol. 2006;  154 753-758
• 5 Casanueva FF, Molitch ME, Schlechte JA. et al . Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.  Clin Endocrinol (Oxf). 2006;  65 265-273
• 6 Colao A, Di Somma C, Pivonello R. et al . Medical therapy for clinically non-functioning pituitary adenomas.  Endocr Relat Cancer. 2008;  15 905-915
• 7 Comtois R, Beauregard H, Somma M. et al . The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas.  Cancer. 1991;  68 860-866
• 8 Daly AF, Rixhon M, Adam C. et al . High Prevalence of Pituitary Adenomas: a cross-sectional Study in the Province of Liege, Belgium.  J Clin Endocrinol Metab. 2006;  91 4769-4775
• 9 Dekkers OM, van der Klaauw AA, Pereira AM. et al . Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma.  J Clin Endocrinol Metab. 2006a;  91 3364-3369
• 10 Dekkers OM, Pereira AM, Roelfsema F. et al . Observation Alone after Transsphenoidal Surgery for Nonfunctioning Pituitary Macroadenoma.  J Clin Endocrinol Metab. 2006b;  91 1796-1801
• 11 Dekkers OM, Hammer S, de Keizer RJ. et al . The natural course of non-functioning pituitary macroadenomas.  Eur J Endocrinol. 2007a;  156 217-224
• 12 Dekkers OM, de Keizer RJ, Roelfsema F. et al . Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma.  Pituitary. 2007b;  10 61-65
• 13 Dekkers OM, Pereira AM, Romijn JA. Treatment and follow-up of clinically non-functioning pituitary macroadenomas.  J Clin Endocrinol Metab. 2008;  93 3717-3726
• 14 Donadio F, Barbieri A, Angioni R. et al . Patients with macroprolactinaemia: clinical and radiological features.  Eur J Clin Invest. 2007;  37 552-557
• 15 Ezzat S, Asa SL, Couldwell WT. et al . The prevalence of pituitary adenomas: a systematic review.  Cancer. 2004;  101 613-619
• 16 Feldkamp J, Santen R, Harms E. et al . Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormonesecreting adenomas - results of a prospective study.  Clin Endocrinol (Oxf). 1999;  51 109-113
• 17 Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).  Clin Endocrinol (Oxf). 2010;  72 377-382
• 18 Ferrante E, Ferraroni M, Castrignanò T. et al . Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors.  Eur J Endocrinol. 2006;  155 823-829
• 19 Gittoes NJ, Bates AS, Tse W. et al . Radiotherapy for non-functioning pituitary tumors.  Clin Endocrinol (Oxf). 1998;  48 331-337
• 20 Greenman Y, Ouaknine G, Veshchev I. et al . Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.  Clin Endocrinol (Oxf). 2003;  58 763-769
• 21 Greenman Y, Stern N. Non-functioning pituitary adenomas.  Best Pract Res Clin Endocrinol Metab. 2009;  23 625-638
• 22 Jaffe CA. Clinically non-functioning pituitary adenoma.  Pituitary. 2006;  9 317-321
• 23 Karavitaki N, Thanabalasingham G, Shore HC. et al . Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.  Clin Endocrinol (Oxf). 2006;  65 524-529
• 24 Karavitaki N, Collison K, Halliday J. et al . What is the natural history of nonoperated nonfunctioning pituitary adenomas?.  Clin Endocrinol (Oxf). 2007;  67 938-943
• 25 Kerrison JB, Lynn MJ, Baer CA. et al . Stages of improvement in visual fields after pituitary tumor resection.  Am J Ophthalmol. 2000;  130 813-820
• 26 Molitch ME. Pituitary tumours: pituitary incidentalomas.  Best Pract Res Clin Endocrinol Metab. 2009;  23 667
• 27 Mortini P, Losa M, Barzaghi R. et al . Results of transsphenoidal surgery in a large series of patients with pituitary adenoma.  Neurosurgery. 2005;  56 1222-1233
• 28 Mortini P, Barzaghi R, Losa M. et al . Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients.  Neurosurgery. 2007;  60 993-1002
• 29 Nielsen EH, Lindholm J, Bjerre P. et al . Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma.  Clin Endocrinol (Oxf). 2006;  64 319-322
• 30 Nielsen EH, Lindholm J, Laurberg P. et al . Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function.  Pituitary. 2007;  10 67-73
• 31 Nomikos P, Ladar C, Fahlbusch R. et al . Impact of primary surgery on pituitary function in patients with non-functioning adenomas-a study on 721 patients.  Acta Neurochir (Wien). 2004;  146 27-35
• 32 O’Sullivan EP, Woods C, Glynn N. et al . The natural history of surgically treated but radiotherapy naúve nonfunctioning pituitary adenomas.  Clin Endocrinol (Oxf). 2009;  71 709-714
• 33 Park P, Chandler WF, Barkan AL. et al . The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas.  Neurosurgery. 2004;  55 100-106
• 34 Saeger W, Lüdecke DK, Buchfelder M. et al . Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.  Eur J Endocrinol. 2007;  156 203-216
• 35 Shahlaie K, McLaughlin N, Kassam AB. et al . The role of outcomes data for assessing the expertise of a pituitary surgeon.  Curr Opin Endocrinol Diabetes Obes. 2010;  17 369-376
• 36 St-Jean E, Blain F, Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.  Clin Endocrinol (Oxf). 1996;  44 305-309
• 37 Wichers-Rother M, Hoven S, Kristof RA. et al . Non-Functioning Pituitary Adenomas: Endocrinological and Clinical Outcome after Transsphenoidal and Transcranial Surgery.  Exp Clin Endocrinol Diabetes. 2004;  112 323-327

Correspondence